A major 18-kD IgE-binding protein from Aspergillusfumigates (Aspf I) has been purified . Partial amino acid sequencing of Asp f I showed extensive sequence homology (95%) between Asp fI and a cytotoxin (mitogillin) produced byA . restrictus. Crossinhibition radioimmunoassay using murine monoclonal antibody and human IgG and IgE antibodies showed that AspfI and mito were antigenically indistinguishable. Furthermore, both proteins inhibited protein synthesis in vitro by >90%. Asp fI was expressed in A . fumigates but not in seven other Aspergillus species . The results suggest that AspfI could play a dual role in the pathogenesis of A . fumigates-related diseases by promoting colonization through cytotoxic activity and by causing inflammatory reactions involving IgE antibodies .
Aspergillus fumigates causes a diverse spectrum of human diseases, including allergic bronchopulmonary aspergillosis (ABPA), asthma, aspergilloma, and invasive infection in immunocompromised hosts (1) . The respiratory tract of patients with chronic pulmonary diseases, particularly cystic fibrosis (2, 3), is frequently colonized by A . fumigates . However, despite the ability of the fungus to cause tissue invasion, respiratory colonization by A . fumigates is often regarded as saprophytic or benign . Serologic studies have shown that colonization can induce IgG and/or IgE antibodies to several A . fumigatus antigens (4-7), however, the structure and function of these antigens are largely unknown . In this report, we describe the purification of an 18-kD IgE-binding protein from A . fumigatus (Asp f I) that is selectively expressed in A . fumigatus . Structural, functional, and antigenic analyses show that Asp f I is a member of the mitogillin family of cytotoxins (8, 9) .
Materials and Methods
Purification of Asp fI. A. fumigates culture (30 g, strain no. 5167; Greer Laboratories, Lenoir, NC) was extracted overnight in 300 ml borate-buffered saline, pH 8.0 (BBS), and centrifuged (20,200 g, 30 min) . A. fumigatus antigens were partially purified from the supernate by gel filtration and phenyl-Sepharose chromatography. A panel of six murine IgG1 mAbs was raised against an N20-kD, 2 M N2CI phenyl-sepharose fraction . mAb 4A6 showed the highest binding to the I'll 2 M fraction in RIA and recognized an 18-kD protein. This protein, AspfI, was purified by affinity chromatography over mAb 4A6 immunosorbent followed by size exclusion HPLC using a Sepharose 12 HR 10/30 column (Pharmacia Fine Chemicals, Piscataway, NJ) . The yield was Wing Asp f I. Purity was assessed by SDS-PAGE using an 8-25% gel on a PhastSystem (Pharmacia Fine Chemicals) .
AminoArid Sequencing. 100pg AspfI was reduced and alkylated using 0.5% (vol/vol) 2-ME and 4% (vol/vol) vinyl pyridine and injected onto a reverse-phase HPLC column (C8 ; Brownlee Labs, Santa Clara, CA). The NH2-terminal amino acid sequence (27 residues) of the HPLC peak was determined using a gas phase sequencer (477-A; Applied Biosystems, Inc ., Foster City, CA). Four tryptic peptides (Ts, Tz, (29) (30) (31) (32) (33) (34) (35) (36) (37) (38) T3, (43) (44) (45) (46) (47) (48) (49) (50) (51) (52) (53) (54) (55) (56) (57) (58) (59) (60) and T4, (121) (122) (123) (124) (125) (126) (127) (128) were sequenced as single sharp peaks from a reversephase HPLC column (C18 ; Applied Biosystems, Inc.) A CNBr fragment was also sequenced (residues 87-107) .
IgE Antibody Assays. mAb 4A6 was used in a solid-phase RIA to present Asp fI to IgE antibodies. Bound IgE antibodies were detected by the addition of 2 ng affinity-purified, '211-labeled goat anti-human IgE . Specific IgE antibody to AspfI or to mitogillin was also determined by double antibody antigen-binding RIA (10) . IgE antibody to A.fumigates was measured by quantitative radioallergosorbent test (RAST) (11) .
Crossinhibition RIA. Serial fourfold or 10-fold dilutions of cold AspfI or mitogillin were incubated for 2 h with 60 ng mAb 4A6 or with 0 .1 ml 1/4 or 1/25 dilution of serum from a patient with ABPA (l.H .) for the IgE and IgG assays, respectively. Subsequently, 6 ng of 121 1 AspfI or 4 ng'uI mitogillin was added for 2 h, and antigen-antibody compleates were precipitated overnight using monospecific goat or sheep antisera (10) . Precipitates were washed with BBS and counted in a gamma counter.
Inhibition ofProtein Synthesis. AspfI and mitogillin were used to inhibit protein synthesis in a rabbit reticulocyte lysate in vitro translation system for Brome Mosaic Virus (Promega Biotec, Madison, WI) . Asp fI or mitogillin was added at 0.3-80 ng/ml in 7 gl RNAase free distilled water. Total "S-methionine incorporation (TCA precipitable counts) was determined by adding 7 ttl distilled water only, and a reaction mixture containing no BMV mRNA was used to determine background counts .
Human Sera and Skin Testing. Sera were obtained from six nonallergic control subjects and from 46 patients who had either positive immediate skin tests or serum IgE antibodies to A.fumigates and clinical symptoms of ABPA (n = 14), cystic fibrosis and ABPA (n = 21), or asthma (n = 11) . Intradermal skin tests were carried out using' serial 10-fold dilutions of Asp f I, from 10-10 -6 I~g/ml (10) .
Results and Discussion
We initially raised a mAb (clone 4A6) against partially purified A . fumigates antigen and found that it recognized a single 18AD band on immunoprecipitation . The mAb was used in a solid-phase RIA to present the antigen to human IgE antibodies. Of 13 patients with ABPA or asthma and positive serum IgE antibodies to A .fumigates (RAST > 200 U/ml), 11 (85%) had IgE antibodies to the 18-kD antigen .
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Patients with equivocal or weakly positive A .fumigates RAST (n = 10 ; geometric mean, 29.5 U/ml) had no detectable IgE antibody. These results showed that the 18-kD antigen defined by mAb 4A6 was an important allergen . The allergen was purified by affinity chromatography and size exclusion HPLC (Fig. 1 A) and has provisionally been designated Aspf I. Partial amino acid sequencing of Asp f I showed extensive sequence homology (95%) between Asp f I and mitogillin, a cytotoxin produced by A . restrictus (Fig. 1 B) . Mitogillin is a member of a family of cytotoxins that includes a-sarcin and restrictocin, produced by A . giganteus and A . restrictus, respectively. These cytotoxins are potent inhibitors of protein synthesis and act by cleaving the 3' end of the large RNA from the 60S ribosomal subunit (9) . Mitogillin also causes regression of murine and canine tumors in vivo (12) . Linear regression analysis showed an excellent quantitative correlation between IgE antibodies to AspfI and to mitogillin (Fig.  2) . On immediate skin testing, four of five patients with positive prick tests to A .fumigates gave positive intradermal skin tests (> 6 x 6-mm wheal) to Aspf I at 10 -2-10 -6 Ug/ml) . In contrast, two patients with positive skin tests to other allergens, but not to A . fumigates, and four nonatopic controls, gave negative skin tests to 10 ug/ml Asp f I. We investigated the antigenic and functional relationships between Asp f I and mitogillin by crossinhibition RIA and by inhibition of cell-free protein synthesis in vitro . Superimposable, dose-dependent inhibition curves were obtained using cold Asp f I or mitogillin to inhibit the binding of either 125 1-labeled proteins to mAb 4A6 or to human IgG or IgE antibody (Fig . 3) . This effect was species specific in that extracts of seven other Aspergillus species, representative of distinct classification groups of the Aspergilli (13), caused <10% inhibition . Together, these results showed that Aspf I and mitogillin were antigenically indistinguishable . Using rabbit reticulocyte lysate to synthesize Brome Mosaic Virus protein, we observed >90% inhibition o£ protein synthesis by both mitogillin and AspfI at concentrations of <20 ng/ml (Table   O   100 1). Inhibition of protein synthesis by either molecule was not blocked by mAb 4A6, suggesting that the epitope recognized by mAb 4A6 is not located near the active site for ribosomal cleavage (Table 1) . A. fumigatus is the most common member of the genus Aspergillus that is associated with human disease, however, the reasons why A.fumigatus frequently colonizes the lungs are poorly understood (14, 15) . Cytotoxic metabolites of A . fumigatus (e.g., gliotoxin and fumagillin) are thought to facilitate fungal growth by inhibiting macrophage function and causing immunosuppression (15, 16) . Unlike Asp f I, none of the low molecular weight metabolites induce IgE antiSerial fourfold dilutions of either Asp f I or mitogillin were used to inhibit incorporation of 35S-methionine in an in vitro translation system for BMV protein. Incorporation of 35S-methionine into protein was determined by TCA precipitation, and the results are expressed as cpm incorporated ( x 103) . In addition, for each reaction tube, the TCA precipitable counts were divided by the total counts added, and the percentage inhibition of the acid precipitable counts as compared with uninhibited controls is shown in parentheses. The estimated dose for 50% inhibition was 4 ng/ml for AspfI and 0.25 ng/ml for mitogillin . In a parallel experiment, we included the major cat allergen, Fel d I, at 20 jig/ml, as a negative control and observed <2% inhibition of protein synthesis. 
